|
1
|
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
|
Pharmacol Ther
|
2010
|
1.57
|
|
2
|
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.
|
Psychopharmacology (Berl)
|
2009
|
0.94
|
|
3
|
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
|
J Psychopharmacol
|
2011
|
0.90
|
|
4
|
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
|
Psychopharmacology (Berl)
|
2010
|
0.84
|
|
5
|
Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
|
Eur Neuropsychopharmacol
|
2010
|
0.82
|
|
6
|
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
|
Int J Neuropsychopharmacol
|
2010
|
0.82
|
|
7
|
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats.
|
Behav Brain Res
|
2009
|
0.82
|
|
8
|
PD168077, a D(4) receptor agonist, reverses object recognition deficits in rats: potential role for D(4) receptor mechanisms in improving cognitive dysfunction in schizophrenia.
|
J Psychopharmacol
|
2010
|
0.81
|
|
9
|
Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
|
Psychopharmacology (Berl)
|
2009
|
0.79
|